Subscribe


PD breaking news – Codeine rescheduling decision deferred

Codeine products to remain OTC until at least 2017. 

The Health Department has just announced the deferral of a final decision on the possible rescheduling of codeine, due to the “large number of submissions received during the most recent consultation period”.

The delay will allow the submissions and subsequent information provided to be thoroughly considered, as well as allowing the delegate to seek further advice prior to making a final ruling, which will not be before 23 June 2016, while any implementation (if required) would not become effective before 2017.

A revised scheduling proposal has been recommended for consideration by the Advisory Committee on Medicines Scheduling, which could still see the current S3 entry for codeine deleted and replaced by Schedule 4, due to issues including morbidity, toxicity and dependence.

However “consideration could also include whether all current Schedule 3 preparations should be rescheduled to Schedule 4, or whether any rescheduling to Schedule 4 should only apply to combination analgesic products containing codeine,” the department said in an update just released.

Consideration could include whether the Schedule 2 entry for codeine should also be amended, the update added.

127 submissions were received, with the vast majority (113) not supporting the up-scheduling proposal.

Full details in tomorrow’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 19 Nov 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

17 Jan

Ibuprofen Double Strength 400 - ARROW Pharmaceuticals announces the launch of Chemists' ...


17 Jan

Fragonia Pure Essential Oil - IN Essence Australian Native Fragonia Pure Essential ...


17 Jan

Banana Powder by Australis - AUSTRALIS Banana Powder is a multipurpose pressed ...


17 Jan

Brain Active from Blackmores - BLACKMORES develops products and services that deliver ...


17 Jan

Dispensary Corner 17 Jan 18 - RECENT data compiled by BMJ Case Reports ...


17 Jan

Priceline aces Kooyong Classic - PRICELINE Pharmacy returned to Melbourne's Kooyong Classic ...


17 Jan

Busting for a laugh - THERE'S no doubt about the comedic creativity ...


17 Jan

Fake paracetamol - THE Therapeutic Goods Administration (TGA) is calling ...


17 Jan

Blackmores check - BLACKMORES has launched a new online Wellbeing ...


17 Jan

Clozapine survey - THE Pharmacy Guild of Australia is currently ...


17 Jan

APP 2018 a sellout - MORE than 450 stands will see pharmacy ...


17 Jan

PSA seals diabetes deal - THE Pharmaceutical Society of Australia (PSA) has ...


16 Jan

Guild Update 16 Jan 18 - MEDSASSIST - the real time recording system ...


16 Jan

Dispensary Corner 16 Jan 18 - IF IT'S true that smoking can stunt ...


16 Jan

Another AD drug fail - EVER elusive, yet another drug that showed ...


16 Jan

PBA call for board members - THE Pharmacy Board of Australia is currently ...


16 Jan

Busting for a script? - PATIENTS visiting the Chemist Warehouse pharmacy in ...


16 Jan

New Arrow items - ARROW Pharmaceuticals has announced the launch of ...


16 Jan

Blockchain an answer - TECHNOLOGY research and development standards group IEEE ...


16 Jan

Apr price disclosure - THE Therapeutic Goods Administration has published its ...



Show Pharmacy Daily items by month: